Clinical Trials
Clinical trials are research studies designed to see if a new treatment is safe and effective. JSG offers clinical trials through our partner, Susquehanna Research Group (SRG).
Clinical Trials Through JSG & SRG
Clinical trials are used to evaluate if a new treatment is more effective and/or has fewer side effects than the standard treatment. Clinical Trials also give patients access to the latest innovations in care. We are excited to offer these opportunities to our qualified patients. You can read more about our sites active clinical trials below and at ClinicalTrials.gov.
Clinical Trials Available at JSG
The trial records located in the National Institute of Health’s U.S. National Library of Medicine include eligibility criteria, the intervention or treatment, completion dates and more information. JSG currently has active clinical trials available to our patients in the areas of moderately active ulcerative colitis, active eosinophilic esophagitis, colorectal cancer and various colorectal cancer screenings. Learn more about these individual trails below.
C-Diff »
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Colorectal Cancer »
Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast
Colorectal Cancer Detection: »
Freenome
A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation To evaluate the performance characteristics of Signal-C™ a plasma circulating free-DNA test, to detect colorectal cancer and advanced precancerous lesions (APL) in an average risk screening population for 45 and over.
Crohn’s »
A phase 2b, multicenter, double-blind, placebo-controlled, study to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of obefazimod in subjects with moderately to severely active Crohn’s disease.
Click to Learn More
Diabetic Gastroparesis »
CinDome- A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis
EOE »
NSI-8226-201- Uniquity One- A Phase 2, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study with an Open-Label Extension to Investigate the Efficacy and Safety of Solrikitug in Adults with Eosinophilic Esophagitis (ALAMERE)
HCC Detection »
ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk
IBS-D »
CinPhloro- A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D)
UC »
Abivax – A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Study to Evaluate the Efficacy and Safety of ABX464 Once Daily for Induction Treatment in Subjects With Moderately to Severely Active Ulcerative Colitis